Secondly, this unbalanced ratio favoring the nuclear presence of the receptor in advanced lung cancers could be a sign of potential or actual activity of VD signaling pathways since the VDR must be transferred to the nucleus for the main VD-cascade reactions to begin and function correctly. This evidence concerns the gene VDR and lung carcinoma.